Prevalence of congenital anomalies in pregnancies complicated by type 2 diabetes: Systematic review and meta-analysis
- PMID: 40682407
- DOI: 10.1002/ijgo.70369
Prevalence of congenital anomalies in pregnancies complicated by type 2 diabetes: Systematic review and meta-analysis
Abstract
Objective: The prevalence of congenital anomalies in pregnancies affected by type 2 diabetes remains uncertain. This study systematically reviews the literature and assesses the prevalence and potential risk factors associated with congenital anomalies in this population.
Method: We searched MEDLINE, Embase, Cochrane, LILACS, and Web of Science for studies published between January 1990 and May 2025 reporting on congenital anomalies in pregnancies complicated by pregestational type 2 or overt diabetes (diabetes first diagnosed at any time during pregnancy). The search included terms such as "congenital anomaly," "birth defect," "pregnancy outcome," "type 2 diabetes," and "non-insulin dependent diabetes mellitus." We included studies with at least 40 pregnancy outcomes, in any language (if minimally translatable), excluding case reports, congress abstracts, and studies focused on chromosomal or genetic syndromes. Search strategies were developed and executed by two librarians. Titles and abstracts were screened, and data were extracted from full-text articles by at least two authors. Analyses were conducted using SPSS v25 and PERSyst-MA (R package meta, v7.0-0). Reporting followed the MOOSE and PRISMA statements.
Results: Of 2316 records, 68 studies met inclusion criteria, representing 102 963 pregnancies and 96 015 outcomes (90 450 with pregestational type 2 diabetes; 5565 with overt diabetes). The overall prevalence of congenital anomalies was 6.1% (95% confidence interval: 5.1%-7.3%; prediction interval: 1.5%-21.6%; I2 = 97%). Cardiac anomalies were most common (21.6%). Subgroup analyses did not yield significant findings; however, meta-regression revealed an inverse association between maternal age and the prevalence of congenital anomalies and a direct association with HbA1c levels.
Conclusion: Type 2 diabetes in pregnancy was associated with a relevant prevalence of congenital anomalies. Lower maternal age and, as expected, higher HbA1c levels increased the risk of congenital anomalies. Regarding the inverse association between congenital anomalies and maternal age, further confirmatory studies are necessary.
Keywords: congenital anomaly; pregnancy; prevalence; type 2 diabetes.
© 2025 International Federation of Gynecology and Obstetrics.
References
REFERENCES
-
- Birth defects surveillance: a manual for programme managers. 2020.
-
- World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract. 2014;103(3):341‐363.
-
- Simmons D. Paradigm shifts in the Management of Diabetes in pregnancy: the importance of type 2 diabetes and early hyperglycemia in pregnancy: the 2020 Norbert Freinkel award lecture. Diabetes Care. 2021;44(5):1075‐1081.
-
- Wahabi HA, Fayed A, Esmaeil S, et al. Systematic review and meta‐analysis of the effectiveness of pre‐pregnancy care for women with diabetes for improving maternal and perinatal outcomes. PLoS One. 2020;15(8):e0237571. doi:10.1371/journal.pone.0237571
-
- Clement NS, Abul A, Farrelly R, et al. Pregnancy outcomes in type 2 diabetes: a systematic review and meta‐analysis. Am J Obstet Gynecol. 2025;232(4):354‐366.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
